Front Page Rotating items of Impact on Children
CureSearch is pleased to announce the appointment of John Polson, Chairman and Managing Partner of Fisher Phillips, to our Board of Directors.
CureSearch for Children’s Cancer Welcomes John Polson to Board of Directors Read More »
We’re thrilled to celebrate Frank Gioscia, a longtime Ultimate Hike champion, who has officially surpassed $500,000 in lifetime fundraising—a milestone that makes him Ultimate Hike’s top fundraiser of all time!
Ultimate Hiker Frank Gioscia raises $500K for Childhood Cancer Research Read More »
Pediatric low-grade glioma (pLGG) is the most common form of pediatric brain cancer. Day One’s OJEMDA™ is the first targeted treatment for pLGG tumors with BRAF fusions and mutations. Last week, on April 23, 2024, Day One Biopharmaceuticals was granted Accelerated
Media Contact: Bailey Singletary240-235-2204Bailey.Singletary@curesearch.org Trent Demulling and David Whan Join CureSearch for Children’s Cancer Board of Directors BETHESDA, MD – August 14, 2020 – CureSearch for Children’s Cancer is pleased to announce the appointment of Trent Demulling and David Whan
CureSearch for Children’s Cancer Announces Board of Directors Additions Read More »
